vortioxetine (as vortioxetine hydrobromide) 5 MG Oral Tablet

RxCUI: 1439812
RxNorm name: vortioxetine (as vortioxetine hydrobromide) 5 MG Oral Tablet
Display name: vortioxetine (as vortioxetine hydrobromide) 5 MG Oral Tablet
Full name: vortioxetine (as vortioxetine hydrobromide) 5 MG Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Trintellix	VORTIOXETINE	REMEDYREPACK INC.	bd0107e5-1cb9-4b40-a6af-fa65fcbe6b4e	2026-04-23	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1439812
Trintellix	VORTIOXETINE	Takeda Pharmaceuticals America, Inc.	1a5b68e2-14d0-419d-9ec6-1ca97145e838	2025-03-05	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1439812

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
1a5b68e2-14d0-419d-9ec6-1ca97145e838	vortioxetine 5 MG Oral Tablet	PSN	18	These highlights do not include all the information needed to use TRINTELLIX ® safely and effectively. See full prescribing information for TRINTELLIX. TRINTELLIX (vortioxetine) tablets, for oral use Initial U.S. Approval: 2013	20250305
1a5b68e2-14d0-419d-9ec6-1ca97145e838	vortioxetine 5 MG Oral Tablet	SCD	18	These highlights do not include all the information needed to use TRINTELLIX ® safely and effectively. See full prescribing information for TRINTELLIX. TRINTELLIX (vortioxetine) tablets, for oral use Initial U.S. Approval: 2013	20250305
1a5b68e2-14d0-419d-9ec6-1ca97145e838	vortioxetine (as vortioxetine hydrobromide) 5 MG Oral Tablet	SY	18	These highlights do not include all the information needed to use TRINTELLIX ® safely and effectively. See full prescribing information for TRINTELLIX. TRINTELLIX (vortioxetine) tablets, for oral use Initial U.S. Approval: 2013	20250305
bd0107e5-1cb9-4b40-a6af-fa65fcbe6b4e	vortioxetine (as vortioxetine hydrobromide) 5 MG Oral Tablet	SY	2	These highlights do not include all the information needed to use TRINTELLIX ® safely and effectively. See full prescribing information for TRINTELLIX. TRINTELLIX (vortioxetine) tablets, for oral use Initial U.S. Approval: 2013	20260423
bd0107e5-1cb9-4b40-a6af-fa65fcbe6b4e	vortioxetine 5 MG Oral Tablet	SCD	2	These highlights do not include all the information needed to use TRINTELLIX ® safely and effectively. See full prescribing information for TRINTELLIX. TRINTELLIX (vortioxetine) tablets, for oral use Initial U.S. Approval: 2013	20260423
bd0107e5-1cb9-4b40-a6af-fa65fcbe6b4e	vortioxetine 5 MG Oral Tablet	PSN	2	These highlights do not include all the information needed to use TRINTELLIX ® safely and effectively. See full prescribing information for TRINTELLIX. TRINTELLIX (vortioxetine) tablets, for oral use Initial U.S. Approval: 2013	20260423